Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
for Advanced Solid Tumor
Drug: CX-5461
6 locations incl. Santa Monica
Sponsor: Senhwa Biosciences, Inc.
Sex: All·Age: 18+
Code: NCT04890613·Phase 1·Recruiting